Science Explorer Back to mapMap
Discussion
Researcher · Kanazawa Medical Center · Japan

Toshiyuki Kita

Toshiyuki Kita publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Physiology, on topics such as Asthma and respiratory diseases, Lung Cancer Treatments and Mutations and Lung Cancer Diagnosis and Treatment.

ORCID 0000-0001-6158-7683 OpenAlex
World rank
#2,280,768
of 7,710,434 ranked researchers
Rank in Japan
#44,186
of 383,136
Works
255
Citations
4.6k
Citations per work
18.1
h-index
30
i10-index 75Top 8.8% in Pulmonary and Respiratory Medicine
Toshiyuki Kita

What does Toshiyuki Kita research?

Toshiyuki Kita's work is mostly in Medicine (48%), Immunology and Microbiology (4%).

Everything else: 124 works · 48.5% of their workHealth Sciences: 121 works · 47.6% of their workMedicine: 121 works · 47.6% of their workPulmonary and Respiratory Medicine: 53 works · 20.8% of their workSurgery: 19 works · 7.5% of their workPhysiology: 18 works · 7.2% of their workOncology: 18 works · 7.0% of their workCardiology and Cardiovascular Medicine: 13 works · 5.1% of their workLife Sciences: 10 works · 3.9% of their workImmunology and Microbiology: 10 works · 3.9% of their workImmunology: 10 works · 3.9% of their workTHEIR WORKToshiyuki Kita255works
Life Sciences4%Health Sciences48%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else12448.5%
    1. Medicine12147.6%
    1. Immunology and Microbiology103.9%
  1. 1Pulmonary and Respiratory Medicine21% of their works
  2. 2Surgery8% of their works
  3. 3Physiology7% of their works
  4. 4Oncology7% of their works
  5. 5Cardiology and Cardiovascular Medicine5% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Toshiyuki Kita's research?

The keywords of their largest research topics: Clinical Trials, Chemotherapy, Targeted Therapy, Epidemiology, Allergic Diseases, Asthma, ALK Inhibitors and Biomarkers.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Clinical Trials623 topics
  2. Chemotherapy513 topics
  3. Targeted Therapy442 topics
  4. Epidemiology432 topics
  5. Allergic Diseases351 topic
  6. Asthma351 topic
  7. ALK Inhibitors311 topic
  8. Biomarkers312 topics
  9. EGFR Mutations311 topic
  10. Metastasis312 topics
  11. CT Screening201 topic
  12. Lung Cancer201 topic
  13. Chronic Cough181 topic
  14. Cough Reflex Sensitivity181 topic
  15. Genomic Analysis181 topic
  16. Ovarian Cancer181 topic
  17. COPD151 topic
  18. spirometry151 topic
  19. Genomic Profiles131 topic
  20. Small-Cell Lung Cancer131 topic
  21. Clinical Characteristics81 topic
  22. SARS-CoV-281 topic

Where does Toshiyuki Kita work?

Toshiyuki Kita's main affiliation in the publication record is Kanazawa Medical Center, Japan.

How many publications and citations does Toshiyuki Kita have?

OpenAlex counts 255 works and 4,618 citations for Toshiyuki Kita, an h-index of 30, ranking #2,280,768 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Toshiyuki Kita

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Toshiyuki Kita. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.